Abstract
In 2007 I was diagnosed with stage VI mantle cell lymphoma and given 6 months to live. You can probably understand why, given this background, I am delighted to be invited to write this piece. Having spent the past 13 years enduring an unrelated donor stem-cell transplant, many outbreaks of graft-versus-host disease, a donor lymphocyte infusion, and 3 years of extracorporeal photopheresis treatment, I would like to talk about my experience as a patient being involved with cancer on the front line. The evolving role of stem cell transplantationSince the 1950s, haematopoietic stem-cell transplantation (HSCT) has proliferated as a technique and has led to 1 million transplantations worldwide. HSCT is often the only established curative treatment for selected patients with congenital or acquired disorders and is routinely used for the treatment of many haematological malignancies. Although HSCT is becoming increasingly common, it is still a complex technique and accessibility is a persistent problem, particularly in low-resource settings. Full-Text PDF
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call